How to Cite
Abstract
Od kako je sistem renin-angiotenzin-aldosteron (RAAS) opisan, postao je jedan od najčešće proučavanih fizioloških sistema, posebno imajući u vidu da ima veoma značajnu ulogu u regulaciji volumena krvi i sistemskog vaskularnog otpora, te na indirektan način utiče i na arterijski krvni pritisak (KP).
S druge strane, arterijska hipertenzija predstavlja jednu od najznačajnijih bolesti današnjice, koja igra značajnu ulogu ne samo u progresiji bubrežne slabosti već predstavlja i faktor rizika za nastanak terminalne bubrežne insuficijencije. Nekoliko epidemioloških studija ukazuje na činjenicu da 30% varijabilnosti KP nastaje usled genetske predispozicije. Do danas je otkriveno nekoliko RAAS gena koji mogu da imaju uticaj na dugoročnu kontrolu KP, ali je inserciono/delecioni (I/D) polimorfizam gena za angiotenzin konvertujući enzim (ACE) najznačajniji i najviše proučavan.
U ovom pregledu literature predstavićemo dostupne podatke iz literature o uticaju I/D polimorfizma ACE gena na funkciju RAAS regulacije KP. Pomoću posebnog osvrta na sve njegove potencijalne fiziološke uloge, predstavićemo i novi pogled u bubrežnu regulaciju KP, kao i u njegove ostale, ne manje značajne uloge.
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005; 365: 217–23.
Muñoz-Durango N, Fuentes CA, Castillo AE, González-Gómez LM, Vecchiola A, Fardella CE et al. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and CellularMechanisms Involved in End-Organ Damage during Arterial Hypertension. Int J Mol Sci. 2016;17(7). pii: E797.
Warner FJ, Smith AI, Hooper NM, Turner AJ. Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cell Mol Life Sci. 2004 Nov;61(21):2704-13.
Joyner MJ, Charkoudian N, Wallin BG. Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications. Hypertension. 2010 Jul;56(1):10-6.
Putnam K, Shoemaker R, Yiannikouris F, Cassis LA. The renin-angiotensin system: A target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2012; 302: H1219–30.
Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation. 2001 Oct 16;104(16):1985-91.
Sica DA, Gehr TW, Fernandez A. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease. Drug Saf. 2000;22:350–60.
Guyton A, Hall JE, editors. Textbook of medical physiology.13th Ed. New York: Elsevier Inc, USA.2016.
Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005; 289: H2281–H90.
Pacurari M, Kafoury R, Tchounwou PB, Ndebele K. The renin-angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflamm. 2014; 2014:689360.
Liu JC, Hsu YP, Wu SY. Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk.PLoS One. 2016 Sep 15;11(9):e0162588.
Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indianpopulation with hypertension and chronic kidney disease. J Postgrad Med. 2015 Oct-Dec;61(4):230-4.
Jin ZN, Wei YX. Meta analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. J Geriatr Cardiol. 2016 May;13(4):333-43.
Zhao J, Qin X, Li S, Zeng Z. Association between the ACE I/D polymorphism and risk of ischemic stroke: an updated meta-analysis of 47,026 subjects from 105 case-control studies. J Neurol Sci. 2014 Oct 15;345(1-2):37-47.
Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JCM. ACE polymorphisms. Circ Res. 2006 May 12;98(9):1123-33.
Settin A, ElBaz R, Abbas A, Abd-Al-Samad A, Noaman A. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction. J Renin Angiotensin Aldosterone Syst. 2009;10:96–100.
Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, et al. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: The possible role of local renin-angiotensin system. Endocrinology. 2007; 148: 1688–96.
Lin C, Yang HY, Wu CC, Lee HS, Lin YF, Lu KC, et al. Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies.PLoS One. 2014 Jan 31;9(1):e87604.
Zhang YF, Cheng Q, Tang NL, Chu TT, Tomlinson B, et al. Gender difference of serum angiotensin-converting enzyme (ACE) activity in DD genotype of ACE insertion/deletion polymorphism in elderly Chinese. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):547-52.
Biller H, Ruprecht B, Gaede KI, Müller-Quernheim J, Zissel G.Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):139-46.
Lim YK, Retnam L, Bhagavath B, Sethi SK, bin Ali A, Lim SK. Gonadal effects on plasma ACE activity in mice. Atherosclerosis. 2002 Feb;160(2):311-6.
Di Cagno A, Sapere N, Piazza M, Aquino G. ACE and AGTR1 Polymorphisms in Elite Rhythmic Gymnastics. Genetic testing and molecular biomarkers. 2013;17(2):99-103.
Ma F, Yang Y, Li X, Zhou F, Gao C, Li M, Gao L. The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PLoS One. 2013;8(1):e54685.
Saber-Ayad MM, Nassar YS, Latif IA. Angiotensin-converting enzyme I/D gene polymorphism affects early cardiac response to professional training in young footballers. J Renin Angiotensin Aldosterone Syst. 2014;15(3):236-42.
Hruskovicová H, Dzurenková D, Selingerová M, Bohus B, Timkanicová B, Kovács L. The angiotensin converting enzyme I/D polymorphism in long distance runners. J Sports Med Phys Fitness. 2006 Sep;46(3):509-13.
Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359: 641–4.
Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H et al. Association of angiotensin-converting enzyme I/D polymorphism with change in left ventricular mass in respomse to physicall training. Circulation. 1997; 96:741-7.
Tanriverdi H, Kaftan HA, Evrengul H, Dursunoglu D, Turgut G, Kiliç M. QT dispersion and left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I/D polymorphism. Acta Cardiol. 2005;60(4):387-93.
He Q, Fan C, Yu M, Wallar G, Zhang ZF, Wang L, et al. Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression withhypertension in a Chinese population. PLoS One. 2013 Oct 1;8(10):e75870.
Ali A, Alghasham A, Ismail H, Dowaidar M, Settin A. ACE I/D and eNOS E298D gene polymorphisms in Saudi subjects with hypertension. J Renin Angiotensin Aldosterone Syst. 2013 Dec;14(4):348-53.
Diet F, Graf C, Mahnke N, Wassmer G, Predel HG, Palma-Hohmann I, et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes.Eur J Clin Invest. 2001 Oct;31(10):836-42.